CLINICAL_TRIALS
trial_result
· 2009-04-22
Clinical Trial Update: Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors [Phase 1]
Summary
Phase 1 trial of vorinostat (suberoylanilide hydroxamic acid) in patients with advanced solid tumors. The study has completed and results were posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED | Results posted: 2009-04-22